Cardiac magnetic resonance in acute myocarditis and dilated cardiomyopathy

Medical Science Monitor

Volumn 15, Issue 5, 2009, Pages

  Wassmuth, Ralf ^a   Schulz Menger, Jeanette ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Cardiomyopathy; Contrast; Heart; Magnetic resonance imaging; Myocarditis

Indexed keywords

CONGESTIVE CARDIOMYOPATHY; HEART EDEMA; HEART MUSCLE FIBROSIS; HEART VENTRICLE FUNCTION; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERICARDIAL EFFUSION; REVIEW; WALL STRESS;

ACUTE DISEASE; CARDIOMYOPATHY, DILATED; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDITIS;

EID: 66749132956     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Hendel RC, Patel MR, Kramer CM, et al. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/ SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol, 2006; 48: 1475-1497
2. Magnani JW, Dec GW: Myocarditis: current trends in diagnosis and treatment. Circulation, 2006; 113: 876-890 (Pubitemid 43754310)
3. Cooper LT, Baughman KL, Feldman AM et al: The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation, 2007; 116: 2216-2233 (Pubitemid 350060359)
4. Pankuweit S, Richter A, Ruppert V, Maisch B: [Classification of cardiomyopathies and indication for endomyocardial biopsy revisited]. Herz, 2009; 34: 55-62
5. Woodruff JF: Viral myocarditis. A review. Am J Pathol, 1980; 101: 425-484
6. Caforio AL, Calabrese F, Angelini A et al: A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J, 2007; 28: 1326-1333 (Pubitemid 47355977)
7. Kindermann I, Kindermann M, Kandolf R et al: Predictors of outcome in patients with suspected myocarditis. Circulation, 2008; 118: 639-648
8. Karjalainen J, Heikkila J: Incidence of three presentations of acute myocarditis in young men in military service. A 20-year experience. Eur Heart J, 1999; 20: 1120-1125
9. Antman EM, Hand M, Armstrong PW et al: 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol, 2008; 51: 210-247
10. Abdel-Aty H, Boye P, Zagrosek A et al: Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol, 2005; 45: 1815-1822 (Pubitemid 40779862)
11. Bellenger NG, Davies LC, Francis JM et al: Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson, 2000; 2: 271-278 (Pubitemid 32048395)
12. Hoffmann R, von Bardeleben S, ten Cate F et al: Assessment of systolic left ventricular function: a multi-centre comparison of cineventriculography, cardiac magnetic resonance imaging, unenhanced and contrast-enhanced echocardiography. Eur Heart J, 2005; 26: 607-616 (Pubitemid 40461103)
13. Zagrosek A, Abdel-Aty H, Boyé P et al: Cardiac Magnetic Resonance Monitors Reversible and Irreversible Myocardial Injury in Myocarditis. JACC: Cardiovascular Imaging, 2009; 2: 131-138
14. Alfakih K, Plein S, Bloomer T et al: Comparison of right ventricular volume measurements between axial and short axis orientation using steady-state free precession magnetic resonance imaging. J Magn Reson Imaging, 2003; 18: 25-32 (Pubitemid 36791265)
15. Delepine S, Furber AP, Beygui F et al: 3-D MRI assessment of regional left ventricular systolic wall stress in patients with reperfused MI. Am J Physiol Heart Circ Physiol, 2003; 284: H1190-97 (Pubitemid 36348581)
16. Alter P, Rupp H, Rominger MB et al: A new methodological approach to assess cardiac work by pressure-volume and stress-length relations in patients with aortic valve stenosis and dilated cardiomyopathy. Pflugers Arch, 2008; 455: 627-636 (Pubitemid 350160477)
17. Abdel-Aty H, Simonetti O, Friedrich MG: T2-weighted cardiovascular magnetic resonance imaging. J Magn Reson Imaging, 2007; 26: 452-459 (Pubitemid 350194566)
18. Zagrosek A, Wassmuth R, Abdel-Aty H et al: Relation between myocardial edema and myocardial mass during the acute and convalescent phase of myocarditis - a CMR study. J Cardiovasc Magn Reson, 2008; 10: 19
19. Friedrich MG, Strohm O, Schulz-Menger J et al: Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation, 1998; 97: 1802-1809 (Pubitemid 28213624)
20. Gutberlet M, Spors B, Thoma T et al: Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology, 2008; 246: 401-409
21. Kim RJ, Fieno DS, Parrish TB et al: Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation, 1999; 100: 1992-2002 (Pubitemid 29529292)
22. Mahrholdt H, Goedecke C, Wagner A et al: Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation, 2004; 109: 1250-1258 (Pubitemid 38379570)
23. Bohl S, Wassmuth R, Abdel-Aty H et al: Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease. Int J Cardiovasc Imaging, 2008; 24: 597-607
24. Mahrholdt H, Wagner A, Deluigi CC et al: Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation, 2006; 114: 1581-1590 (Pubitemid 44547428)
25. Nazarian S, Bluemke DA, Lardo AC et al: Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation, 2005; 112: 2821-2825 (Pubitemid 41641676)
26. Smedema JP, Snoep G, van Kroonenburgh MP et al: Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol, 2005; 45: 1683-1690 (Pubitemid 40704507)
27. Schulz-Menger J, Wassmuth R, Abdel-Aty H et al: Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance. Heart, 2006; 92: 399-400 (Pubitemid 43295117)
28. Abdel-Aty H, Siegle N, Natusch A et al: Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach. Lupus, 2008; 17: 561-567
29. Wassmuth R, Gobel U, Natusch A et al: Cardiovascular magnetic resonance imaging detects cardiac involvement in Churg-Strauss syndrome. J Card Fail, 2008; 14: 856-860
30. Wassmuth R, Lentzsch S, Erdbruegger U et al: Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging-a pilot study. Am Heart J, 2001; 141: 1007-1013 (Pubitemid 32477014)
31. Maron BJ, Towbin JA, Thiene G et al: Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation, 2006; 113: 1807-1816
32. Elliott P, Andersson B, Arbustini E et al: Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J, 2008; 29: 270-276
33. Koikkalainen JR, Antila M, Lotjonen JM et al: Early familial dilated cardiomyopathy: identification with determination of disease state parameter from cine MR image data. Radiology, 2008; 249: 88-96
34. Osterziel KJ, Strohm O, Schuler J et al: Randomised, double-blind, placebo- controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet, 1998; 351: 1233-1237 (Pubitemid 28181962)
35. Beer M, Wagner D, Myers J et al: Effects of exercise training on myocardial energy metabolism and ventricular function assessed by quantitative phosphorus-31 magnetic resonance spectroscopy and magnetic resonance imaging in dilated cardiomyopathy. J Am Coll Cardiol, 2008; 51: 1883-1891
36. Jerosch-Herold M, Sheridan DC, Kushner JD et al: Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol, 2008; 295: H1234-42
37. Assomull RG, Prasad SK, Lyne J et al: Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol, 2006; 48: 1977-1985 (Pubitemid 44738448)
38. McCrohon JA, Moon JC, Prasad SK et al: Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation, 2003; 108: 54-59 (Pubitemid 36859020)
39. Liu PP, Yan AT: Cardiovascular magnetic resonance for the diagnosis of acute myocarditis: prospects for detecting myocardial inflammation. J Am Coll Cardiol, 2005; 45: 1823-1825 (Pubitemid 40779863)
40. Skouri HN, Dec GW, Friedrich MG, Cooper LT: Noninvasive imaging in myocarditis. J Am Coll Cardiol, 2006; 48: 2085-2093 (Pubitemid 44738442)